Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish whether addition of extra-fine particle steroid
inhalers achieve additional suppression of small airways inflammation when added to
'standard' Fluticasone/Salmeterol combination therapy in refractory asthma.
Phase:
Phase 4
Details
Lead Sponsor:
University of Dundee
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate